Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
about
Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLETMultidrug resistance in bacteriaLipase catalysis in organic solvents: advantages and applicationsRND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibitionRecent advances toward a molecular mechanism of efflux pump inhibitionIdentification of inhibitors of PvdQ, an enzyme involved in the synthesis of the siderophore pyoverdine.Structural basis for the inhibition of bacterial multidrug exportersBacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance DeterminantsThe ins and outs of RND efflux pumps in Escherichia coliIdentification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline)Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channelsHigh-level pacidamycin resistance in Pseudomonas aeruginosa is mediated by an opp oligopeptide permease encoded by the opp-fabI operonIdentification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validationPolyamino-Isoprenic Derivatives Block Intrinsic Resistance of P. aeruginosa to Doxycycline and Chloramphenicol In VitroA peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa.A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase IIMultidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei.Genes involved in intrinsic antibiotic resistance of Acinetobacter baylyi.Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implicationsGenomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosaAssessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporterCurrent Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsAcinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code.Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli.Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.Lack of AcrB Efflux Function Confers Loss of Virulence on Salmonella enterica Serovar Typhimurium.Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilmsDetermination of real-time efflux phenotypes in Escherichia coli AcrB binding pocket phenylalanine mutants using a 1,2'-dinaphthylamine efflux assay.Cost of adaptation and fitness effects of beneficial mutations in Pseudomonas fluorescens.Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistanceDiscovery of a novel and potent class of FabI-directed antibacterial agents
P2860
Q21133536-255DD67F-25B5-496C-A260-538BBD62FE81Q22255652-FD501C46-1986-4AE0-9087-CB409E01DC1BQ26772024-A335CF61-D17C-4A01-AA2D-A1F6ECC759AFQ26827930-232FBA0E-62F0-4EB8-A34B-6A64588BEDEBQ27004685-D1879052-3A1B-4C5B-A0D8-B111A62AF30CQ27683773-A9C100ED-C289-49B6-9EFE-0871DBD2695AQ27685149-99E4CC2F-AA88-478F-A705-D5EFB3EDFE44Q28073636-33D62734-383E-4AC9-96A6-A1827E09C31CQ28084596-00B8C838-EC17-4EAA-BD4C-DCB1C7BDA215Q28473596-17BC37BF-3914-4C3E-89F2-CF01922F72DDQ28477164-C8353878-10FD-4791-82B0-1168F0734E56Q28477724-704A65F1-31F2-4590-8F05-11AE12C1F3ADQ28492727-5D6F869C-9C09-4ABB-9EF7-A94703F123FEQ28540748-035E6AF9-4FEF-4108-8B71-537076F52D7BQ28551861-07DC86C3-CCC2-4BBC-A678-20D3D7121DA6Q30155308-D95D35AC-41EB-4790-80D1-AA0EC3F08EC0Q30448695-BFF9B91C-25E4-4AD0-A802-681BB8F112C0Q30530476-6FC17643-9D99-45D9-9681-64E7FFA28E4CQ33200347-C01C9B6D-5446-48B8-B9B1-1752976F7DF0Q33255734-3722EF7F-5882-4760-A0A7-D2634571EC36Q33259104-FC99ADDD-7602-4A4D-9AC7-6DE1C49D9017Q33424246-11204FD6-3B6D-42C1-B91D-F95871A7E991Q33504396-AF9D8E3D-378E-46D7-905D-956EB6E5B96AQ33533545-1E64C45F-F240-4E48-A65B-4770142080E9Q33555483-807EF630-7EC3-4197-BE50-826050B216D8Q33555822-D355ADDC-6ED8-46AF-8889-908AD38409A4Q33659230-387BA50C-93E6-4BEF-8809-06FDE3E62F5BQ33676136-1F8310FE-6F44-4C50-ACBF-21CC2669B128Q33721943-BEB352A2-704C-46C1-BE4C-1487DD7F3315Q33768891-3B737C15-B162-4994-8EF9-89E9242EC588Q33806021-3E73168D-831F-4BD8-8C1F-8A62F6CA8B5CQ33831880-F5CAA41B-4535-476F-A091-4866B9D3FFF4Q33859639-A38820A8-1617-4EAF-9584-C374B8C5B0BCQ33883691-6E159E75-4FEA-4B1B-8498-666E0A3EED0DQ33916492-8A65C58A-B1CE-424C-AA6F-49D33239D047Q33935451-5F440276-A39C-497A-9EC6-E8B05D987CE0Q33941171-D82B77A8-CB9D-4B4C-AD6C-3FEE8006B10AQ34003200-61790191-8730-4A83-B131-CE0481C4B991Q34102811-0D1FFBC5-1C2D-405B-9819-9948904C421DQ34143489-05634DDE-220E-4306-B55B-1715A97BE9DD
P2860
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Identification and characteriz ...... gents for combination therapy.
@en
Identification and characteriz ...... gents for combination therapy.
@nl
type
label
Identification and characteriz ...... gents for combination therapy.
@en
Identification and characteriz ...... gents for combination therapy.
@nl
prefLabel
Identification and characteriz ...... gents for combination therapy.
@en
Identification and characteriz ...... gents for combination therapy.
@nl
P2093
P2860
P1476
Identification and characteriz ...... gents for combination therapy.
@en
P2093
M S Warren
O Lomovskaya
P2860
P304
P356
10.1128/AAC.45.1.105-116.2001
P407
P577
2001-01-01T00:00:00Z